SCHEMBL972543

SCHEMBL972543

O=C1OCc2nc3c(cc21)C1=C(C3)CN(CC(=O)N2CCN(C3CCC3)CC2)CO1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.35
HTT P42858 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
ALDH1A1 P00352 5/20 0.34
KDM4E B2RXH2 4/20 0.34
HSD17B10 Q99714 2/20 0.34
MAPK1 P28482 1/20 0.34
HRH3 Q9Y5N1 5/20 0.33
MAPT P10636 3/20 0.33
PDE3B Q13370 1/20 0.33
PDE3A Q14432 1/20 0.33
G6PD P11413 1/20 0.33
HPGD P15428 1/20 0.33
CACNA1B Q00975 1/20 0.33
APBA1 Q02410 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
POLB P06746 2/20 0.32
KMT2A Q03164 1/20 0.32
USP2 O75604 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL972542 0.74 PARP1 (0.41) PARP1HTTNPSR1ALDH1A1KDM4E
SCHEMBL971439 0.71 PARP1 (0.35) PARP1ALDH1A1KDM4EHSD17B10MAPK1
SCHEMBL13006689 0.66 MAPT (0.46) PARP1ALDH1A1HRH3MAPTKMT2A
SCHEMBL1016063 0.64 HRH3 (0.38) PARP1HTTNPSR1ALDH1A1KDM4E
SCHEMBL967179 0.64 PARP1 (0.40) PARP1HTTNPSR1ALDH1A1KDM4E
SCHEMBL968523 0.64 PARP1 (0.40) PARP1HTTNPSR1ALDH1A1KDM4E
SCHEMBL1017157 0.64 KDM4E (0.42) PARP1ALDH1A1KDM4EHRH3MAPT
SCHEMBL1017527 0.64 HRH3 (0.41) PARP1HTTNPSR1ALDH1A1KDM4E
SCHEMBL13006700 0.64 ALDH1A1 (0.46) PARP1ALDH1A1KDM4EHRH3MAPT
SCHEMBL1017394 0.64 KDM4E (0.41) PARP1ALDH1A1KDM4EHSD17B10HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES HRH3, HRH4, HRH1 PARP1 2898/4885HTT 661/4885NPSR1 199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.